Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Drugs|April 8, 2016
The Emerging Role of PI3K Inhibitors in the Treatment of Hematological Malignancies: Preclinical Data and Clinical Progress to DateTill Seiler, Grit Hutter, Martin DreylingAnnals of Hematology|August 17, 2004
Promoter methylation and expression of DNA repair genes hMLH1 and MGMT in acute myeloid leukemiaGeorg Lenz, Grit Hutter, Wolfgang Hiddemann, et al.Talanta|January 20, 2010
Combined RNA-expression and 2D-PAGE-screening identifies comprehensive interaction networks affected after bortezomib or enzastaurin exposure of mantle cell lymphomaMarc Weinkauf, Grit Hutter, Yvonne Zimmermann, et al.Leukemia & Lymphoma|August 4, 2015
Temsirolimus inhibits cell growth in combination with inhibitors of the B-cell receptor pathwayAnna-Katharina Zoellner, Stephan Bayerl, Grit Hutter, et al.European Journal of Haematology|April 5, 2018
Transient antagonism of anti-CD20 monoclonal antibodies and PI3K inhibitor idelalisib in DLBCL cell linesAnna-Katharina Zoellner, Nico Peter, Yvonne Zimmermann, et al.The Hematology Journal : the Official Journal of the European Haematology Association|January 28, 2004
Use of polymorphisms in the noncoding region of the human mitochondrial genome to identify potential contamination of human leukemia-lymphoma cell linesGrit Hutter, Christina Nickenig, Henk Garritsen, et al.Annals of Hematology|January 11, 2012
The proteasome inhibitor bortezomib targets cell cycle and apoptosis and acts synergistically in a sequence-dependent way with chemotherapeutic agents in mantle cell lymphomaGrit Hutter, Malte Rieken, Alessandro Pastore, et al.Annals of Hematology|December 15, 2015
Temsirolimus acts as additive with bendamustine in aggressive lymphomaAnna-Katharina Zoellner, Tobias Weiglein, Grit Hutter, et al.Electrophoresis|March 25, 2009
2-D PAGE-based comparison of proteasome inhibitor bortezomib in sensitive and resistant mantle cell lymphomaMarc Weinkauf, Yvonne Zimmermann, Elena Hartmann, et al.Cell Cycle (Georgetown, Tex.)|October 14, 2009
3'UTR mediated regulation of the cyclin D1 proto-oncogeneAnagha Deshpande, Alessandro Pastore, Aniruddha J Deshpande, et al.Pageof 2